Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
SEC Pushes Back on Binance.US and Voyager Deal
SEC Pushes Back on Binance.US and Voyager Deal
Another Hot Reading on Job Market Sends Wall Street Lower
Stocks fell broadly on Wall Street and Treasury yields rose after another hot reading on the job market raised worries that the Federal Reserve will need to continue inflicting pain on the economy to fight inflation.
Morning Alexa Flash Briefings of January 5th
Alexa Flash Briefings
Cheddar Morning News Briefings of January 5th
Cheddar Morning News Briefings
How Your Bonus Will Be Taxed
Kimberly Palmer, personal finance spokesperson at NerdWallet, joined Cheddar News to discuss how your year-end bonus is taxed.
Smart Bird Feeder Can Photograph and Identify 350 Different Species
Smart Bird Feeder Can Photograph and Identify 350 Different Species
Stellantis to Mass Produce Archer Electric Aircraft in an Expanded Deal
Stellantis to Mass Produce Archer Electric Aircraft in an Expanded Deal
Deloitte: More U.S. Consumers Want EVs but Prices Are a Concern
Deloitte: More U.S. Consumers Want EVs but Prices Are a Concern
EU Fines Meta $400M for Targeted Advertising Practices
Ireland Fines Meta $400M for Targeted Advertising Practices
